Peptide Initiative

Peptides · Peptide comparison

Natriuretic Peptide (ANP) vs Thymosin Beta-4

Your heart's natural fluid and pressure regulator, helping restore balance when fluid overload strikes.

The body's natural healing peptide that accelerates tissue repair and reduces inflammation

  • Healing & Recovery
  • Healing & Recovery

At a glance

Quick comparison

Dose rangeNatriuretic Peptide (ANP)0.025–0.050 mcg/kg/minThymosin Beta-42–5 mg
FrequencyNatriuretic Peptide (ANP)Once dailyThymosin Beta-4Twice weekly
AdministrationNatriuretic Peptide (ANP)Intravenous infusion (continuous) - standard hospital delivery methodThymosin Beta-4Subcutaneous injection
Cycle lengthNatriuretic Peptide (ANP)Ongoing/indefiniteThymosin Beta-48-12 weeks
Onset speedNatriuretic Peptide (ANP)Moderate (1-2 weeks)Thymosin Beta-4Moderate (1-2 weeks)
Evidence levelNatriuretic Peptide (ANP)Moderate human trials (Phase 1-2)Thymosin Beta-4Moderate human trials (Phase 1-2)

Efficacy

Benefit ratings

Acute Fluid Management

Natriuretic Peptide (ANP)82%
Thymosin Beta-4No recorded rating

Hemodynamic Stabilization

Natriuretic Peptide (ANP)78%
Thymosin Beta-4No recorded rating

Symptom Relief

Natriuretic Peptide (ANP)74%
Thymosin Beta-4No recorded rating

Wound Healing

Natriuretic Peptide (ANP)No recorded rating
Thymosin Beta-495%

Inflammation Reduction

Natriuretic Peptide (ANP)No recorded rating
Thymosin Beta-488%

Tissue Regeneration

Natriuretic Peptide (ANP)No recorded rating
Thymosin Beta-492%

Technical data

Compound specifications

Natriuretic Peptide (ANP)

Molecular formula
C127H203N45O39S3
Molecular weight
3080.5 g/mol
Half-life
Approximately 15-30 minutes (IV administration)
Bioavailability
100% (intravenous administration)
CAS number
Variable depending on salt form; carperitide CAS: 120399-20-4

Thymosin Beta-4

Molecular formula
C212H350N56O78S
Molecular weight
4963
Half-life
Dose-dependent (increases with higher doses)
Bioavailability
100% (subcutaneous and intravenous)
CAS number
77591-33-4

Protocols

Dosing compared

Natriuretic Peptide (ANP)

Intravenous

  • 0.0125 mcg/kg/min continuous infusionContinuous IV infusion · Up to 72 hoursVery low starting dose used in some acute heart failure cases per Japanese Circulation Society guidance [4]. Hospital-only, titrated to blood pressure.
  • 0.025-0.050 mcg/kg/min continuous infusionContinuous IV infusion · Up to 72 hoursGuideline low-dose range for acute heart failure; associated with better 1-year outcomes than very-low dose [4]. Requires continuous hemodynamic monitoring.

Thymosin Beta-4

Subcutaneous injection

  • 2-5 mg (community injectable practice for 'TB-500')Once or twice weekly · 4-6 week loading phase, then weekly maintenanceDocumented community/research-practice injectable dosing for tissue repair; thymosin beta-4 has ~100% bioavailability by the subcutaneous route [1]. Not an FDA-approved use.

Topical ophthalmic (eye drops)

  • 0.1% (1 mg/mL) RGN-259 solution, 1 dropSeveral times daily (e.g. up to 5x/day) · 4 weeks0.1% RGN-259 ophthalmic solution used in phase III neurotrophic keratopathy and dry-eye trials, applied as eye drops several times daily for ~4 weeks [5].

Intravenous injection

  • 450-1200 mgIV push daily for the first 3 days, then weekly · Total of 7 doses over ~5 weeksDoses studied in the RGN-352 acute myocardial infarction clinical program, given IV after PCI [6].

Applications

Best suited for

Natriuretic Peptide (ANP)

Managing acute decompensated heart failure with fluid overload
Natriuretic Peptide (ANP) is particularly well-suited for individuals focused on managing acute decompensated heart failure with fluid overload. [8][9] Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Relieving shortness of breath caused by pulmonary congestion
Natriuretic Peptide (ANP) is particularly well-suited for individuals focused on relieving shortness of breath caused by pulmonary congestion. [8] Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Lowering elevated blood pressure in emergency cardiac situations
Natriuretic Peptide (ANP) is particularly well-suited for individuals focused on lowering elevated blood pressure in emergency cardiac situations. [5][11] Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Reducing the workload on the heart during acute episodes
Natriuretic Peptide (ANP) is particularly well-suited for individuals focused on reducing the workload on the heart during acute episodes. [11][12] Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Thymosin Beta-4

Post-Surgery Recovery
Accelerates healing of surgical wounds and reduces post-operative inflammation and scarring
Chronic Wound Management
Helps pressure ulcers, venous stasis ulcers, and other slow-healing wounds progress faster
Tissue Regeneration
Supports repair of damaged tissues from injury, burns, or degenerative conditions

Safety profile

Side effects

Natriuretic Peptide (ANP)

Common

  • Mild discomfort at treatment site
  • Hypotension (excessively low blood pressure) requiring close monitoring
  • Headache and dizziness from sudden blood pressure changes
  • Weakness and fatigue during or shortly after treatment
  • Nausea and gastrointestinal discomfort
  • Decreased kidney function temporarily, requiring follow-up monitoring
  • Tremors or shaking sensations
  • Atrial fibrillation (irregular heartbeat) in some patients
  • Abdominal pain
  • Injection site reactions if administered intravenously
  • Renal dysfunction with prolonged use, especially in elderly patients

Serious

  • Severe allergic reaction

Thymosin Beta-4

Common

  • Injection site redness
  • Injection site swelling

Uncommon

  • Temporary mild headache
  • Mild bruising at injection site
  • Transient fatigue

Serious

  • Allergic reaction

Research status

Safety & evidence

Natriuretic Peptide (ANP)

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Exogenous ANP demonstrates excellent safety in Phase II/III cardiac decompensation trials with rapid clearance (2-minute half-life) [6][10] providing inherent safety margins. Hypotension is the expected primary effect, managed through continuous hemodynamic monitoring and dose titration. [9][10] No serious adverse events or carcinogenicity observed in 500+ trial participants. Receptor desensitization with prolonged continuous infusion [5] requires periodic treatment breaks or dose adjustments.

Contraindications

  • Severe kidney failure with very low glomerular filtration rate
  • Recent or ongoing treatment with certain blood pressure medications that may cause dangerous drops in pressure
  • Acute coronary syndrome or recent heart attack where vasodilation could be harmful
  • Severe hypotension or cardiogenic shock without proper supportive care
  • Allergies to ANP, carperitide, or any components of the pharmaceutical formulation

Thymosin Beta-4

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Thymosin Beta-4 is a naturally occurring peptide found in all cells and body fluids in the human body. Clinical trials have demonstrated excellent safety even at very high doses. IV studies showed doses up to 1260 mg were well tolerated with no serious adverse events.

Contraindications

  • Active systemic infections
  • Severe immunosuppression
  • Hypersensitivity to thymosin or any component
  • Pregnancy (insufficient safety data)

Decision guide

Which is right for you?

Natriuretic Peptide (ANP)

Choose Natriuretic Peptide (ANP) if…

  • Managing acute decompensated heart failure with fluid overload
  • Relieving shortness of breath caused by pulmonary congestion
  • Lowering elevated blood pressure in emergency cardiac situations
  • Reducing the workload on the heart during acute episodes

Thymosin Beta-4

Choose Thymosin Beta-4 if…

  • Recovering from injuries or surgery
  • Improving wound healing speed
  • Reducing inflammation
  • Minimizing scar formation